• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Cell Banking Outsourcing Market

    ID: MRFR/LS/17778-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    US Cell Banking Outsourcing Market Research Report By Bank Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), By Cell Type (Stem Cell Banking, Cord Stem Cell Banking, Embryonic Stem Cell Banking, Adult Stem Cell Banking, Dental Stem Cell Banking, IPS Stem Cell Banking, Non-Stem Cell Banking) and By Application (Cell Bank Storage, Master Cell Bank Storage, Working Cell Bank Storage, Cell Storage Stability Testing, Cell Bank Preparation, Master Cell Bank Preparation, Working Cell Bank Preparation, Bank Characterization &amp...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Cell Banking Outsourcing Market Infographic
    Purchase Options

    US Cell Banking Outsourcing Market Summary

    The US Cell Banking Outsourcing market is poised for substantial growth, projected to reach 4607.7 USD Million by 2035.

    Key Market Trends & Highlights

    US Cell Banking Outsourcing Key Trends and Highlights

    • The market valuation is expected to increase from 340.6 USD Million in 2024 to 4607.7 USD Million by 2035.
    • A compound annual growth rate (CAGR) of 26.72 percent is anticipated from 2025 to 2035.
    • This market is likely to experience rapid expansion as demand for cell banking services continues to rise.
    • Growing adoption of advanced biobanking technologies due to increasing research and development activities is a major market driver.

    Market Size & Forecast

    2024 Market Size 340.6 (USD Million)
    2035 Market Size 4607.7 (USD Million)
    CAGR (2025-2035) 26.72%

    Major Players

    Smart Cells, Lifebank USA, CryoStem, PerkinElmer, Advanced Cell Technologies, Tissue Regeneration, CryoCell International, Newborn Stem Cell Bank, StemCyte, Global BioBanking, Cells4Life, Viacord, Cord Blood Registry, FamilyCord, Regenesis Biomedical

    US Cell Banking Outsourcing Market Trends

    In the US, the Cell Banking Outsourcing Market is increasingly shaped by various trends reflecting the evolving landscape of biotechnology and healthcare. One significant market driver is the rising demand for personalized medicine, which is spurring biobanks to expand their services through outsourcing. By partnering with external firms, institutions can focus on core activities while leveraging the expertise and facilities of specialized providers.

    This collaboration enhances efficiency and ensures compliance with stringent regulatory requirements enforced by agencies such as the FDA and CDC, which are critical in maintaining the quality and integrity of biological materials. Opportunities lie in the growing trend of digitalization within the cell banking industry. The integration of advanced technologies such as artificial intelligence and big data analytics can optimize sample management and improve patient recruitment processes.

    In the US, where innovation is at the forefront of healthcare, there is a substantial push for developing sophisticated IT infrastructures that support these activities. Furthermore, with an increasing emphasis on ethical considerations and patient privacy, firms are looking to streamline their practices while ensuring compliance with HIPAA regulations, fostering trust among stakeholders.

    Market Segment Insights

    Cell Banking Outsourcing Market Bank Type Insights

    The US Cell Banking Outsourcing Market is a rapidly evolving field, centered around the essential Bank Type segment, which consists of Master Cell Banking, Working Cell Banking, and Viral Cell Banking. Master Cell Banking acts as a foundational element within this market, focusing on the long-term storage and preservation of cellular materials, which are crucial for future research and therapeutic applications.

    This segment's agility and responsiveness significantly contribute to the overall efficiency of the US Cell Banking Outsourcing Market as it caters to the rising demand for cell-based therapies and innovative drug development. Meanwhile, the Viral Cell Banking segment addresses the growing need for secure storage of viral stocks that are critical for vaccine production as well as gene therapy applications. The focus on biomanufacturing capabilities within the US has positioned this segment to capitalize on opportunities presented by advancements in biotechnology, ultimately boosting the market's growth in the next decade.

    Overall, understanding these Bank Type intricacies is essential for stakeholders aiming to navigate the dynamics of the US Cell Banking Outsourcing Market effectively, especially given the rapid innovation and increasing regulatory complexities in the biopharmaceutical sector. The thriving landscape fueled by advancements in cell therapies, coupled with regulatory support from the US government for biotechnology initiatives, is set to drive expansion and diversification within this market segment.

    As healthcare trends evolve towards more personalized and effective treatments, the relevance of each of these banking types continues to grow, further solidifying their roles in shaping the future of the US Cell Banking Outsourcing Market. The interplay of these various bank types not only influences market dynamics but also reflects broader trends in biotechnology and healthcare innovation across the nation.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Cell Banking Outsourcing Market Cell Type Insights

    The Cell Type segment within the US Cell Banking Outsourcing Market encompasses various crucial categories, each playing a significant role in advancing medical research and therapies. Stem Cell Banking, which includes both Cord Stem Cell Banking and Embryonic Stem Cell Banking, is particularly important due to its potential applications in regenerative medicine and treatment of chronic diseases.

    The diversity of cell types within this market reflects the growing demand for tailored therapies and innovative treatments, driven by advances in biotechnology and an increasing emphasis on personalized medicine in the US healthcare landscape. As the market evolves, the segmentation presents both opportunities and challenges, particularly in regulatory compliance and ethical considerations. Each category contributes to overall market growth and dynamics, reaffirming the integral role the US Cell Banking Outsourcing Market plays in contemporary healthcare.

    Cell Banking Outsourcing Market Application Insights

    The US Cell Banking Outsourcing Market is experiencing significant growth, driven by advancements in biotechnology and increasing demand for personalized medicine. The Application segment encompasses various critical areas, including Cell Bank Storage and its subtypes, which provide vital services for preserving cellular materials essential for research and therapeutic purposes.

    Additionally, comprehensive processes like Cell Bank Preparation, along with Bank Characterization and Testing, play a pivotal role in complying with regulatory standards and maintaining safety through Viral Cell Bank Safety Testing and Microbial Cell Bank Safety Testing. Gene Expression Testing, Karyology Testing, and Gene Sequencing Testing are also fundamental to the market, facilitating the understanding of cellular behavior and genetics, which are essential for the advancement of medical science. Overall, these various facets within the Application segment reflect the ongoing innovation and importance of cell banking in the US healthcare landscape.

    Get more detailed insights about US Cell Banking Outsourcing Market

    Key Players and Competitive Insights

    The US Cell Banking Outsourcing Market is a rapidly evolving sector characterized by increasing demand for stem cell storage, regenerative medicine, and innovative healthcare solutions. This niche market predominantly focuses on the preservation of stem cells derived from umbilical cord blood and tissue, offering valuable resources for future medical use. The competitive landscape within this market is marked by a mix of established players and emerging companies that are constantly innovating to enhance their service offerings, address regulatory challenges, and meet the diverse needs of families considering cell banking.

    Key trends such as advancements in technology, growing awareness about the importance of stem cell therapy, and strategic partnerships between companies are shaping the industry's dynamics, providing various opportunities for growth and expansion.

    Smart Cells stands out in the US Cell Banking Outsourcing Market by cultivating a strong reputation for its excellent customer service and robust operational framework. Known for its comprehensive cell storage solutions, Smart Cells offers advanced technology for the collection and preservation of stem cells, ensuring a high level of quality and integrity. The company prioritizes customer education, providing resources and support to families considering banking their cord blood and tissue. Its strengths lie in maintaining high safety standards, a dedicated research focus, and a commitment to upholding regulatory compliance, which fosters trust among potential clients.

    Smart Cells has also established strategic partnerships with healthcare providers, further solidifying its presence in the market and enhancing patient accessibility to its services.

    Lifebank USA is another key player in the US Cell Banking Outsourcing Market, recognized for its extensive range of stem cell banking services including the collection, processing, and cryopreservation of umbilical cord blood and tissue. The company has built a solid market presence with a focus on quality and reliability, utilizing state-of-the-art technology for stem cell storage. Lifebank USA's strengths are reflected in its commitment to customer support, educational initiatives, and scientific advancements in regenerative medicine. The firm is actively involved in research and development, enhancing its capability to provide value-added services to clients, thereby maintaining competitiveness.

    Lifebank USA has strategically pursued partnerships and collaborations to leverage the latest advancements in the field, along with pursuing mergers and acquisitions that broaden its service offerings and geographical reach, solidifying its status within the US market.

    Key Companies in the US Cell Banking Outsourcing Market market include

    Industry Developments

    Recent news in the US Cell Banking Outsourcing Market highlights significant developments and activities concerning key players like Smart Cells, Lifebank USA, and CryoStem. In July 2023, CryoCell International announced its expansion of services, focusing on innovative cryopreservation techniques that enhance its operational capabilities within the market.

    In September 2022, Viacord launched a new initiative to streamline the processing of cord blood and tissue, aiming to improve customer access and efficiency. Additionally, in November 2021, Global BioBanking made news with its strategic partnership involving Advanced Cell Technologies, which boosts collaborative Research and Development efforts, focusing on regenerative medicine.

    The market valuation for companies involved in cell banking outsourcing has shown growth, with an increasing demand for stem cell therapies contributing to this trend. Regulatory frameworks have also evolved, facilitating advancements in sourcing and processing technologies. In line with these developments, several companies are investing heavily in infrastructure upgrades, including Newborn Stem Cell Bank and StemCyte, to scale their operations. This environment is indicative of a robust interest in cell banking solutions aimed at supporting personalized medicine, a sector that has seen steady growth over the past few years.

    Market Segmentation

    Cell Banking Outsourcing Market Bank Type Outlook

    • Master Cell Banking
    • Working Cell Banking
    • Viral Cell Banking

    Cell Banking Outsourcing Market Cell Type Outlook

    • Stem Cell Banking
    • Cord Stem Cell Banking
    • Embryonic Stem Cell Banking
    • Adult Stem Cell Banking
    • Dental Stem Cell Banking
    • IPS Stem Cell Banking
    • Non-Stem Cell Banking

    Cell Banking Outsourcing Market Application Outlook

    • Cell Bank Storage
    • Master Cell Bank Storage
    • Working Cell Bank Storage
    • Cell Storage Stability Testing
    • Cell Bank Preparation
    • Master Cell Bank Preparation
    • Working Cell Bank Preparation
    • Bank Characterization & Testing
    • Viral Cell Bank Safety Testing
    • Microbial Cell Bank Safety Testing
    • Gene Expression Testing
    • Karyology Testing
    • Gene Sequencing Testing

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 293.83(USD Million)
    MARKET SIZE 2024 340.55(USD Million)
    MARKET SIZE 2035 4607.69(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 26.72% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Smart Cells, Lifebank USA, CryoStem, PerkinElmer, Advanced Cell Technologies, Tissue Regeneration, CryoCell International, Newborn Stem Cell Bank, StemCyte, Global BioBanking, Cells4Life, Viacord, Cord Blood Registry, FamilyCord, Regenesis Biomedical
    SEGMENTS COVERED Bank Type, Cell Type, Application
    KEY MARKET OPPORTUNITIES Increasing demand for personalized medicine, Growth in biobanking collaborations, Advancements in cell preservation technologies, Expanding research in regenerative medicine, Rising investment in biotechnology sectors.
    KEY MARKET DYNAMICS Growing biobank demand, Regulatory compliance pressures, Cost optimization strategies, Technological advancements in processing, Increased collaboration in research
    COUNTRIES COVERED US

    FAQs

    What is the expected market size of the US Cell Banking Outsourcing Market in 2024?

    The US Cell Banking Outsourcing Market is expected to be valued at 340.55 million USD in 2024.

    What will be the market value of the US Cell Banking Outsourcing Market by 2035?

    By 2035, the US Cell Banking Outsourcing Market is projected to reach a valuation of 4607.69 million USD.

    What is the projected CAGR for the US Cell Banking Outsourcing Market from 2025 to 2035?

    The market is expected to grow at a CAGR of 26.72% during the forecast period from 2025 to 2035.

    Which bank type is expected to dominate in terms of market size by 2035?

    Master Cell Banking is anticipated to dominate the market, projected to reach 2000.0 million USD by 2035.

    What are the expected market values for Working Cell Banking in 2024 and 2035?

    The Working Cell Banking market is expected to be valued at 120.55 million USD in 2024 and projected to reach 1600.0 million USD by 2035.

    What is the market value for Viral Cell Banking in 2024 and its expected growth by 2035?

    Viral Cell Banking is expected to be valued at 70.0 million USD in 2024 and forecasted to grow to 1007.69 million USD by 2035.

    Who are the major players in the US Cell Banking Outsourcing Market?

    Key players include Smart Cells, Lifebank USA, CryoStem, PerkinElmer, and CryoCell International among others.

    What challenges and opportunities exist in the US Cell Banking Outsourcing Market?

    The market faces challenges related to regulatory issues, yet offers opportunities through technological advancements and increasing demand for cell-based therapies.

    What are the key applications driving growth in the US Cell Banking Outsourcing Market?

    Key applications driving growth include regenerative medicine, transplantation, and research purposes.

    How is the US Cell Banking Outsourcing Market expected to be impacted by the current global scenario?

    The market outlook remains positive overall, with anticipated growth despite potential disruptions from geopolitical conflicts.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials